Jane Street Group, LLC Mannkind Corp Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 926,734 shares of MNKD stock, worth $5.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

926,734

Previous 579,795 59.84%

Holding current value

$5.23 Million

Previous $3.03 Million 92.3%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $1.74 Million - $2.32 Million	346,939 Added 59.84%	926,734 $5.82 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $1.16 Million - $1.55 Million	285,605 Added 97.08%	579,795 $3.03 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $414,082 - $671,450	-127,410 Reduced 30.22%	294,190 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $477,042 - $612,727	142,827 Added 51.23%	421,600 $1.53 Million
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $634,115 - $883,870	-162,178 Reduced 36.78%	278,773 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $1.2 Million - $1.55 Million	322,700 Added 272.89%	440,951 $1.79 Million
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $1.36 Million - $1.94 Million	-344,142 Reduced 74.43%	118,251 $484,000
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $1.32 Million - $2.34 Million	435,444 Added 1615.81%	462,393 $2.44 Million
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $305,407 - $444,322	-102,143 Reduced 79.12%	26,949 $83,000
Q2 2022 Aug 16, 2022	BUY	$2.67 - $4.77 $141,269 - $252,380	52,910 Added 69.45%	129,092 $492,000
Q1 2022 May 17, 2022	BUY	$2.62 - $4.45 $78,138 - $132,716	29,824 Added 64.33%	76,182 $280,000
Q4 2021 Feb 15, 2022	SELL	$4.05 - $5.37 $125,841 - $166,856	-31,072 Reduced 40.13%	46,358 $203,000
Q3 2021 Nov 16, 2021	BUY	$3.89 - $5.48 $33,870 - $47,714	8,707 Added 12.67%	77,430 $337,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $59,781 - $90,252	16,560 Added 31.75%	68,723 $375,000
Q1 2021 May 18, 2021	BUY	$3.14 - $6.14 $67,189 - $131,383	21,398 Added 69.55%	52,163 $204,000
Q4 2020 Feb 17, 2021	SELL	$1.79 - $4.04 $7,390 - $16,681	-4,129 Reduced 11.83%	30,765 $96,000
Q3 2020 Nov 17, 2020	SELL	$1.56 - $2.08 $145,098 - $193,464	-93,012 Reduced 72.72%	34,894 $66,000
Q2 2020 Aug 17, 2020	BUY	$0.94 - $2.21 $120,231 - $282,672	127,906 New	127,906 $224,000
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $248,926 - $521,560	-296,341 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.14 - $1.49 $144,553 - $188,933	126,801 Added 74.79%	296,341 $382,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.44 $91,349 - $126,483	-87,836 Reduced 34.13%	169,540 $212,000
Q2 2019 Aug 15, 2019	SELL	$1.09 - $1.88 $55,506 - $95,735	-50,923 Reduced 16.52%	257,376 $296,000
Q1 2019 May 16, 2019	BUY	$1.14 - $2.25 $351,460 - $693,672	308,299 New	308,299 $607,000
Q4 2017 Feb 15, 2018	SELL	$2.28 - $6.71 $159,821 - $470,350	-70,097 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $80,611 - $160,522	70,097	70,097 $153,000

Others Institutions Holding MNKD

# of Institutions

250

Shares Held

149M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.45B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Mannkind Corp Transaction History